Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Medical device marketing is the advertising and promotion of a device by its maker or distributor: web pages, ads, brochures, case studies, gated guides and sales emails. This page is for device makers, distributors and the people who write their copy. After reading it you should be able to check any asset against the claim rules before it goes out. It is general regulatory information, not legal advice.
What counts as marketing a device
For regulatory purposes the label is not the only thing that counts. Under 21 CFR 801.4, the intended use of a device is the objective intent of the people responsible for its labeling, and that intent may be shown by labeling claims, advertising matter, or oral or written statements. So a landing page, a sales deck and a webinar script are all evidence of what a device is intended to do.
Who regulates device advertising: FDA and FTC
Two agencies matter. Under 21 USC 352(q), a restricted device is misbranded if its advertising is false or misleading in any particular, and 352(r) requires restricted-device advertisements to carry specified statements, including a true statement of the device’s established name. The Federal Trade Commission publishes its Health Products Compliance Guidance, which covers health equipment, diagnostic tests and apps, and includes an example of a Class II cleared device. In short, FDA’s authority reaches device labeling and restricted-device advertising, and FTC guidance applies to health product advertising, including cleared devices.
Claims and intended use
Three rules from 21 CFR 801.4 shape what an ad may say:
- Marketing statements can establish intended use. A claim in an ad is treated as evidence of the use the firm intends.
- A later seller or distributor whose intended uses differ from the manufacturer’s must supply labeling that matches those uses.
- A firm is not deemed to intend an unapproved new use solely because it knows healthcare providers use a cleared device that way.
For prescription devices, 21 CFR 801.109 requires the “Rx only” caution statement and requires the information for use to cover all purposes for which the device is advertised or represented. Copy that promises a purpose missing from the labeling creates a gap. For labeling basics, see FDA labeling requirements for medical devices; for distributors, see the medical device distribution agreement guide.
Cleared is not approved
Under 21 CFR 807.97, 510(k) clearance does not in any way denote official approval of the device, and any representation that implies approval is misleading and misbranding. Marketing copy should say “cleared” for a 510(k) device and should not use “FDA approved”. See why “FDA certified” is not an FDA status and what a K number identifies.
Substantiation and testimonials
The FTC guidance says health claims need a reasonable basis before they run, with the standard being competent and reliable scientific evidence. Randomized controlled trials are generally expected; animal studies, in vitro results or anecdotes alone are not enough, and evidence must not be cherry-picked. For case studies and reviews, the guidance says it is not enough that a testimonial represents the honest opinion or experience of an endorser, that paid endorsers’ material connections must be disclosed clearly and conspicuously, and that “results not typical” does not cure a claim.
Channels: digital marketing, SEO, content marketing and lead generation
Medical device digital marketing and SEO
Search ads, product pages and optimized articles are advertising matter like any other. The claim rules above apply to the copy: the intended-use rule in 21 CFR 801.4 reaches advertising matter, and FTC guidance applies to advertising in any medium, so the rules are the same whatever the channel.
Medical device content marketing and lead generation
Blog posts, case studies, white papers and gated guides that describe what a device does can show intended use, and any testimonial or customer story in them falls under the FTC endorsement points above. Treat each asset as a claim-bearing document, not as neutral education.
Pre-publish claim checklist
| Asset or statement | Check before publishing | Source |
|---|---|---|
| Product page, ad, deck or webinar describing what the device does | Do the stated uses match the cleared labeling? Statements can establish intended use. | 21 CFR 801.4 |
| Distributor brochure with uses different from the manufacturer’s | Labeling matching those uses must be supplied. | 21 CFR 801.4 |
| Copy noting that providers use a cleared device off its cleared use | Knowledge alone does not make the firm intend that use. | 21 CFR 801.4 |
| Wording such as “FDA approved” on a 510(k) device | Use “cleared”; implying approval is misleading. | 21 CFR 807.97 |
| Prescription device promotion | Information for use covers all advertised purposes; “Rx only” statement present. | 21 CFR 801.109 |
| Advertisement for a restricted device | Not false or misleading; required statements including established name. | 21 USC 352(q), (r) |
| Health or performance claim | Reasonable basis: competent and reliable scientific evidence, not cherry-picked. | FTC Health Products Compliance Guidance |
| Testimonial, review or case study | Honest opinion alone is not enough; disclose paid endorsers’ material connections clearly and conspicuously. | FTC Health Products Compliance Guidance |
Pay arrangements for sales channels are covered in medical device sales commission; the checklist above applies to the copy those channels use.
FAQ
Can I say my device is FDA approved?
Not if it was cleared through a 510(k). 21 CFR 807.97 says clearance does not denote official approval and that implying approval is misleading and misbranding.
Does SEO or content marketing for a device follow different rules?
No. The claim rules in 21 CFR 801.4 and FTC guidance apply to any advertising matter, whatever the channel, so web pages, articles and lead-generation assets are held to the same claim rules.
Can a customer testimonial be used in device marketing?
Yes, but FTC guidance says an endorser’s honest opinion is not enough on its own, paid endorsers’ connections must be disclosed clearly and conspicuously, and “results not typical” does not cure a claim.
Who polices medical device ads?
FDA, through misbranding provisions for restricted-device advertising and labeling rules, and the FTC, whose Health Products Compliance Guidance covers health products including cleared devices.
Sources
- 21 CFR 801.4, Meaning of intended uses, eCFR, checked 2026-11-01.
- 21 CFR 807.97, Misbranding by reference to premarket notification, eCFR, checked 2026-11-01.
- 21 CFR 801.109, Prescription devices, eCFR, checked 2026-11-01.
- 21 USC 352, Misbranded drugs and devices, Cornell LII, checked 2026-11-01.
- FTC, Health Products Compliance Guidance, ftc.gov, checked 2026-11-01.







